Modified chitin binding domain and uses thereof
AssigneeNew England Biolabs, Inc.
InventorsMing-Qun Xu, Sebastien M. Ferrandon, Christopher H. Taron, Paul A. Colussi
Life of this patent
Estimating the term…
Loading patent…
AssigneeNew England Biolabs, Inc.
InventorsMing-Qun Xu, Sebastien M. Ferrandon, Christopher H. Taron, Paul A. Colussi
Estimating the term…
Compositions and methods are provided for reversibly binding chitin binding domain (CBD) to a chitin or equivalent substrate under non denaturing conditions. CBD is modified preferably by a mutation to achieve this change in properties. In one embodiment, an aromatic amino acid residue located in the binding cleft of the CBD was altered resulting in reversible binding affinity for substrate in select conditions. Creating a modified CBD with an altered binding affinity for substrate provides new uses for CBD not previously possible with unmodified CBD which binds irreversibly to chitin.
A protein comprising:
A method of obtaining a chitin binding domain (CBD) capable of reversibly binding to a chitin substrate under non-denaturing conditions, the method comprising:
A method for producing and purifying a target protein molecule comprising:
A method for purifying a chitin binding domain-target molecule conjugate from a mixture of molecules in a preparation comprising:
A kit for purifying a recombinant protein, comprising:
A fusion vector for constructing an expression vector which expresses a modified chitin binding domain (CBD) fused to a protein molecule to be purified, comprising:
A DNA expression vector for producing a purified protein molecule, which upon expression produces a chitin binding domain fused to the protein molecule, comprising:
A vector comprising a sequence for a mutant CBD and optionally an insertion site for placing a sequence encoding a recombinant protein within or adjacent to the CBD sequence.
Dependencies are inferred from the claim text.